Skip to main content

Abbvie Inc(ABBV-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume

Latest News

ABBVIE INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of AbbVie Inc. - ABBV
Business Wire - Fri Aug 12, 9:50PM CDT
Business Wire
Fri Aug 12, 9:50PM CDT
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into AbbVie Inc. (NYSE: ABBV).
Are Medtronic And Intuitive Surgical Poised For Big Growth?
MarketBeat - Tue Aug 9, 9:00AM CDT
MarketBeat
Tue Aug 9, 9:00AM CDT
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently.
Two Appealing Biotech Stocks for Two Distinct investors
MarketBeat - Mon Aug 8, 10:00AM CDT
MarketBeat
Mon Aug 8, 10:00AM CDT
Investing in biotech stocks carries both risk and reward. This article highlights two biotech companies that may appeal to specific investing styles
3 Unstoppable Stocks That Don't Care About the Bear Market
Motley Fool - Sun Aug 7, 8:00AM CDT
Motley Fool
Sun Aug 7, 8:00AM CDT
When the market is falling, this trio keeps rising.
3 Unstoppable Dividend Stocks to Buy in August
Motley Fool - Sat Aug 6, 5:08AM CDT
Motley Fool
Sat Aug 6, 5:08AM CDT
Income investors have a lot to like about these stocks.
3 Reasons Why AbbVie Stock Could Be Approaching a Make or Break Moment
Motley Fool - Fri Aug 5, 9:00AM CDT
Motley Fool
Fri Aug 5, 9:00AM CDT
It won't be able to rely on Humira for growth for much longer.
3 Pharma Stocks' Post-Earnings Price Moves
MarketBeat - Thu Aug 4, 5:05AM CDT
MarketBeat
Thu Aug 4, 5:05AM CDT
The health care sector is participating in the S&P's nascent rally, but pharmaceuticals AbbVie, Merck and Pfizer are holding up well relative to the market.
FDA Approves JUVÉDERM® VOLUX™ XC for Improvement of Jawline Definition
PR Newswire - Wed Aug 3, 7:45AM CDT
PR Newswire
Wed Aug 3, 7:45AM CDT
/PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of JUVÉDERM® VOLUX™ XC for the improvement of...
Sosei Heptares and AbbVie Enter New Multi-target Collaboration to Discover, Develop and Commercialize Novel Medicines Targeting Neurological Diseases
Globe Newswire - Mon Aug 1, 6:05PM CDT
Globe Newswire
Mon Aug 1, 6:05PM CDT
New strategic collaboration leverages Sosei Heptares’ StaR® technology and SBDD platform and AbbVie’s extensive neuroscience expertise Second collaboration...
If You Invested $25,000 in Abbott Laboratories in 2013, This Is How Much You Would Have Today
Motley Fool - Sun Jul 31, 6:55AM CDT
Motley Fool
Sun Jul 31, 6:55AM CDT
The real question may be, has Abbott been a better buy than AbbVie since the spinoff?